---
title: "Baxter International Inc. (BAX.US) Q1 2022 Earnings Conference Call"
description: "Baxter International is committed to providing a basic portfolio of renal and hospital products, including acute and chronic dialysis, sterile intravenous infus"
locale: "en"
url: "https://longbridge.com/en/lives/11034"
parent: "https://longbridge.com/en/lives.md"
category: "Earnings Call"
---

# Baxter International Inc. (BAX.US) Q1 2022 Earnings Conference Call

**Status**: Unknown
**Category**: Earnings Call

## Description

Baxter International is committed to providing a basic portfolio of renal and hospital products, including acute and chronic dialysis, sterile intravenous infusion, infusion systems and equipment, parenteral nutrition therapy, premixed and oncolytic injections, biologics and surgical products and anesthesia drugs, drug recombination system and pharmacy automation, software and services. It operates through the following market segments: Americas, Europe, Middle East and Africa (EMEA), Asia Pacific (APAC) and Hillrom. The Americas, EMEA and APAC market segments offer a basic healthcare product portfolio. The Hillrom segment provides digital and interconnected care solutions and collaborative tools, including smart bed systems, patient monitoring and diagnostic technology, respiratory health equipment and advanced equipment for surgical fields. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, Illinois.

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.